1
TÍTULO: Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials  Full Text
AUTORES: Kimball, Alexa B.; Jemec, Gregor B. E.; Alavi, Afsaneh; Reguiai, Ziad; Gottlieb, Alice B.; Bechara, Falk G.; Paul, Carle; Bourboulis, Evangelos J. Giamarellos; Villani, Axel P.; Schwinn, Andreas; Rueff, Franziska; Ramaya, Larisha Pillay; Reich, Adam; Lobo, Ines; Sinclair, Rodney; Passeron, Thierry; Martorell, Antonio; Mendes Bastos, Pedro; Kokolakis, Georgios; Becherel, Pierre Andre; Wozniak, Magdalena B.; Martinez, Angela Llobet; Wei, Xiaoling; Uhlmann, Lorenz; Passera, Anna; Keefe, Deborah; Martin, Ruvie; Field, Clarice; Chen, Li; Vandemeulebroecke, Marc; Ravichandran, Shoba; Muscianisi, Elisa; ...Mais
PUBLICAÇÃO: 2023, FONTE: LANCET, VOLUME: 401, NÚMERO: 10378
INDEXADO EM: Scopus WOS
2
TÍTULO: Efficacy of secukinumab in patients with moderate-to-severe hidradenitis suppurativa previously treated with biologic therapy: Week 16 results from the SUNSHINE and SUNRISE trials  Full Text
AUTORES: Zouboulis, Christos C.; Passeron, Thierry; Bastos, Pedro Mendes; Pariser, David; Offidani, Annamaria; Kasparek, Torben; Wozniak, Magdalena; Li, Xianjun; Uhlmann, Lorenz; Muscianisi, Elisa;
PUBLICAÇÃO: 2023, FONTE: Annual Meeting of the American-Academy-of-Dermatology (AAD) in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, VOLUME: 89, NÚMERO: 3
INDEXADO EM: WOS